Urgent.News

What's breaking now, across thousands of outlets.

Editions

Health & Medicine

Genentech invests $750M in new factory; Bavarian Nordic delays Lyme trial

🏭 Genentech’s new $750M factory: Roche’s Genentech is investing $750 million in a new drug delivery device facility at its site in Hillsboro, OR, which is expected to be operational in ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Friday 21 August →